129 related articles for article (PubMed ID: 19086459)
21. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy.
Sargın G; Şentürk T; Ceylan E; Telli M; Çildağ S; Doğan H
Tuberk Toraks; 2018 Jun; 66(2):136-143. PubMed ID: 30246657
[TBL] [Abstract][Full Text] [Related]
22. Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.
Gupta D; Kumar S; Aggarwal AN; Verma I; Agarwal R
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):95-101. PubMed ID: 22117500
[TBL] [Abstract][Full Text] [Related]
23. QuantiFERON-TB Gold assay for the diagnosis of latent tuberculosis infection.
Manuel O; Kumar D
Expert Rev Mol Diagn; 2008 May; 8(3):247-56. PubMed ID: 18598104
[TBL] [Abstract][Full Text] [Related]
24. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.
Detjen AK; Keil T; Roll S; Hauer B; Mauch H; Wahn U; Magdorf K
Clin Infect Dis; 2007 Aug; 45(3):322-8. PubMed ID: 17599309
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis of tuberculosis infection using interferon-γ-based assays.
Santín Cerezales M; Domínguez Benítez J
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():26-33. PubMed ID: 21420564
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays.
Mori T
J Infect Chemother; 2009 Jun; 15(3):143-55. PubMed ID: 19554399
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
[TBL] [Abstract][Full Text] [Related]
28. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
Matsumoto T; Yamazaki T
Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
[TBL] [Abstract][Full Text] [Related]
29. Interferon-γ release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a literature review.
Chiappini E; Bonsignori F; Accetta G; Boddi V; Galli L; Biggeri A; De Martino M
Int J Immunopathol Pharmacol; 2012; 25(2):335-43. PubMed ID: 22697065
[TBL] [Abstract][Full Text] [Related]
30. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis.
Simsek H; Alpar S; Ucar N; Aksu F; Ceyhan I; Gözalan A; Cesur S; Ertek M
Jpn J Infect Dis; 2010 Mar; 63(2):99-102. PubMed ID: 20332570
[TBL] [Abstract][Full Text] [Related]
31. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States.
Mazurek GH; Jereb J; Lobue P; Iademarco MF; Metchock B; Vernon A;
MMWR Recomm Rep; 2005 Dec; 54(RR-15):49-55. PubMed ID: 16357824
[TBL] [Abstract][Full Text] [Related]
32. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection.
Vinton P; Mihrshahi S; Johnson P; Jenkin GA; Jolley D; Biggs BA
Infect Control Hosp Epidemiol; 2009 Mar; 30(3):215-21. PubMed ID: 19191484
[TBL] [Abstract][Full Text] [Related]
33. Discrepancy between Mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation.
Leyten EM; Arend SM; Prins C; Cobelens FG; Ottenhoff TH; van Dissel JT
Clin Vaccine Immunol; 2007 Jul; 14(7):880-5. PubMed ID: 17507543
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the QuantiFERON?-TB Gold In-Tube assay and tuberculin skin test for the diagnosis of Mycobacterium tuberculosis infection in northeastern Thailand.
Reechaipichitkul W; Pimrin W; Bourpoern J; Prompinij S; Faksri K
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):236-44. PubMed ID: 26342121
[TBL] [Abstract][Full Text] [Related]
35. The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.
Chen YM; Chen HH; Lai KL; Hung WT; Lan JL; Chen DY
Rheumatology (Oxford); 2013 Apr; 52(4):697-704. PubMed ID: 23264552
[TBL] [Abstract][Full Text] [Related]
36. T cell-based diagnosis of childhood tuberculosis infection.
Lalvani A; Millington KA
Curr Opin Infect Dis; 2007 Jun; 20(3):264-71. PubMed ID: 17471036
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of an in vitro assay for gamma interferon production in response to Mycobacterium tuberculosis infections.
Taggart EW; Hill HR; Ruegner RG; Martins TB; Litwin CM
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1089-93. PubMed ID: 15539511
[TBL] [Abstract][Full Text] [Related]
38. Interferon gamma release assay in diagnosis of pediatric tuberculosis: a meta-analysis.
Sun L; Xiao J; Miao Q; Feng WX; Wu XR; Yin QQ; Jiao WW; Shen C; Liu F; Shen D; Shen AD
FEMS Immunol Med Microbiol; 2011 Nov; 63(2):165-73. PubMed ID: 22077219
[TBL] [Abstract][Full Text] [Related]
39. Absence of interferon-gamma release assay conversion following tuberculin skin testing.
Ritz N; Yau C; Connell TG; Tebruegge M; Leslie D; Curtis N
Int J Tuberc Lung Dis; 2011 Jun; 15(6):767-9. PubMed ID: 21575296
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of latent tuberculosis infection: the potential role of new technologies.
Kunst H
Respir Med; 2006 Dec; 100(12):2098-106. PubMed ID: 16650976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
